The sialyl-glycolipid stage-specific embryonic antigen 4 marks a subpopulation of chemotherapy-resistant breast cancer cells with mesenchymal features

Overview of attention for article published in Breast Cancer Research, November 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

news: 1 news outlet
twitter: 3 X users

patent: 1 patent

Citations

dimensions_citation: 58 Dimensions

Readers on

mendeley: 83 Mendeley

Summary News X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

SSEA4 and ST3GAL2 as chemotherapeutic drug response biomarkers

Application EP-2927328-B1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.